Akebia Therapeutics, Inc. (AKBA)
1.60
+0.01
(+0.63%)
USD |
NASDAQ |
Dec 31, 15:23
Akebia Therapeutics Market Cap: 424.59M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 141.60B |
| Plus Therapeutics, Inc. | 70.36M |
| Ironwood Pharmaceuticals, Inc. | 541.72M |
| Pyxis Oncology, Inc. | 72.23M |
| Theravance Biopharma, Inc. | 956.19M |
Market Cap Related Metrics
| PS Ratio | 1.787 |
| Price to Book Value | 10.21 |
| Price to Free Cash Flow | 12.50 |
| Price | 1.60 |
| Earnings Yield | -4.76% |
| Operating PE Ratio | 22.67 |